A Guide to Fiscal Year 1991 Federal Funding for HIV Disease: How Dollars are Spent How to Access Them

Anyone seeking funds through NIH or other Federal venues should keep in mind that all monies allocated
for extramural projects will be divided between competing and non-competing projects. For example, of
the numbers above, a portion will be awarded to new applicants and a portion to institutions or groups
previously funded through an on-going program or award. The period for such continuing programs generally
averages between three to five years, and continued funding is contingent on the grantee performing according to all guidelines and requirements.
Although some local AIDS/HIV organizations may not qualify individually for awards made through the
NIH, they should explore developing coalitions and cooperative efforts with local education or medical
institutions which would comprise a group eligible to compete for NIH funding. Local organizations should
also make inquiries to various NIH departments and the NIH Office of Communications regarding the
availability of any printed materials developed on HIV research, education, or treatment, in order to be
better informed to assist constituents.
At this point in FY '91, nearly all NIH extramural funding has either been awarded or is earmarked for
applications and proposals currently in the evaluation system. However, announcements related to FY '92
funding will be forthcoming. All NIH AIDS/HIV awards are made, as mandated by Congress, within a
six-month period from application deadlines. In this way, federal monies will flow continuously into the
field for ongoing programs and research on this critical issue.
Information on NIH AIDS/HIV extramural funding through contracts and grants may be obtained, as
already described, in the CBD or Federal Register. In addition, NIH publishes a weekly NIH Guide for Grants
and Contracts, available free of charge, which includes information on all AIDS/HIV extramural funding.
See Appendix C for information on ordering the NIH Guide.
For additional information on NIH AIDS/HIV extramural funding, contact:
Joyce Piotrowski
Office of AIDS Research
301/496-0545
National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) conducts a multifaceted, comprehensive program on AIDS/HIV. Basic research focuses on increasing the understanding of the structure of
HIV and its pathogenic process, as well as the body's immune responses to HIV infection. Epidemiologic
studies in a variety of population groups in the United States and around the world are the basis for information on the natural history of the disease and its transmission. The development and testing of new drugs
through its AIDS Clinical Trial Groups (ACTGs) and other research programs, and strategies for treating
HIV disease and its various manifestations are top priorities. NIAID is also involved in a program to test
AIDS vaccines in uninfected humans and supporting research to develop other potential vaccine therapies
for infected and uninfected individuals.
NIAID FY '91 HIV Funding
1. Basic Science Research.............................................. $ 368,288,000
Biomedical Research:
HIV and HIV genome................................ $ 31,094,000
Immunology....................................... 38,729,000
Blood/Blood products.................................. 401,000
Diagnostic methods/reagents development................. 10,666,000
Animal models and related studies....................... 19,548,000
Neuroscience and Neuropsychiatric Research................ 4,834,000
Behavioral Research:
Mechanisms of behavior and behavior

change.............................................. 275,000
Prevention of high-risk behavior......................... 579,000

30

Reproduction By Permission Only

~1991 ASAP

30 Reproduction By Permission Only ~1991 ASAP